2 postdoc positions in W. Wahli’s lab in Singapore

Capture d’écran 2014-11-10 à 11.20.46

Lee Kong Chian School of Medicine invites applications for:


Research Fellows in the Laboratory of Dr. Xiaomeng Wang and Prof Walter Wahli


Lee Kong Chian School of Medicine (LKCMedicine) is a new joint medical school by Imperial College London and Nanyang Technological University, Singapore. It was established in September 2010 and will operate from two campuses – Yunnan Campus at Nanyang Technological University and a new campus to be built at Novena. Its primary healthcare partner is the National Healthcare Group (NHG), which comprises an integrated network of primary healthcare polyclinics, acute care hospitals such as Tan Tock Seng Hospital, and national specialty centres. Lee Kong Chian School of Medicine will deliver a new five-year undergraduate medical programme resulting in a joint degree (MBBS) awarded by Imperial College London and Nanyang Technological University.


LKCMedicine is currently recruiting two Research Fellows who will be working closely with Assistant Professor Xiaomeng Wang and Professor Walter Wahli at LKCMedicine on studying the role of a novel regulator of TGFβ signalling, LRG1, and its interaction with the metabolic regulators PPARs in cancer growth and progression, with the ultimate aims to develop novel therapeutics for the treatment of cancer.



The appointed Research Fellows will be involved in projects which use in vitro and in vivo disease models to investigate:

  • The role of LRG1 in cancer cell signalling and function


  • The role of LRG1 in cancer vasculature formation


  • The therapeutic potential of targeting LRG1 for the treatment of cancer


These posts will have the opportunity to work in a dynamic environment with experienced molecular and cell biologists, and geneticists. The appointed Research Fellows will also have access to leading edge core facilities.


Successful candidates will have a MD-PhD or a PhD qualification in biochemistry and cell/molecular biology. Previous experience in cancel cell biology, angiogenesis and mouse genetics will be desirable. Previous publications in international peer reviewed journals are a prerequisite.


Application Procedure:


If you are interested to pursue a career with the School, please apply to Dr. Andrew Ang, Director, research administration and support services (email: andrewang@ntu.edu.sg) with your CV, list of publications, statement of research interests and names of three references at your earliest convenience. For further queries, you may write to Dr. Xiaomeng Wang (email:wangxiaomeng@ntu.edu.sg) and Prof. Walter Wahli (walter.wahli@ntu.edu.sg).


Only shortlisted candidates will be notified.


Closing date: 31 Dec 2014